News

Rakeiora Seminar

Tēnā Kotou Katoa, The Centre for Cancer Research (CCR) is proud to have started pur 2022 Seminar Series with the Flagship Seminar led by Prof. Cris Print on Thursday 31st March at 1pm. CCR have identified this seminar as foundational due to the central focus on...

Doctors call for ban on insurers accessing genetic tests

Doctors call for ban on insurers accessing genetic tests

A group of academics called AGenDA wrote an editorial in NZMJ detailing genetic discrimination in New Zealand. This video explains how this occurs and features CCR Director Andrew Shelling. Watch out for a cameo from CCR Director Peter Browett (masked and chatting to Andrew)

Advocates want ban on insurers accessing genetic test results

Advocates want ban on insurers accessing genetic test results

A top medical researcher says many patients decline vital genetic tests out of fear they could lose their insurance cover because of it.
Auckland University Centre for Cancer Research acting director Professor Andrew Shelling said that was wrong and it must stop.
He’s part of a group of clinicians, researchers and patient advocates who are calling for a ban on insurers accessing New Zealanders’ genetic test results.
Professor Shelling spoke to Corin Dann.

Take a look at your impact – THYmine2

Take a look at your impact – THYmine2

Over the past 3 years, your support has funded the THYmine2 clinical study. The study is investigating an innovative new test to identify if a patient undergoing treatment for gut cancers is at risk of life-threatening side effects. Lead investigator Dr Nuala Helsby discusses the difference the test could make, and the importance of your support in making it happen. Funding from the CCR Li Family Funding Round enabled this research to succeed and we are so proud of the researchers involved and their award of further funding.